Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.
about
Effects of sodium citrate and acid citrate dextrose solutions on cell counts and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gelWhite blood cell concentration correlates with increased concentrations of IL-1ra and improvement in WOMAC pain scores in an open-label safety study of autologous protein solution.Intra-Articular Injections of Platelet-Rich Plasma versus Hyaluronic Acid in the Treatment of Osteoarthritic Knee Pain: A Randomized Clinical Trial in the Context of the Spanish National Health Care SystemNew developments in the treatment of osteoarthritis - focus on biologic agents.Safety and Treatment Effectiveness of a Single Autologous Protein Solution Injection in Patients with Knee Osteoarthritis.Evaluation of a Single Intra-Articular Injection of Autologous Protein Solution for Treatment of Osteoarthritis in a Canine Population.Inflammation-induced transgene expression in genetically engineered equine mesenchymal stem cells.Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma.An Autologous Anti-Inflammatory Protein Solution Yielded a Favorable Safety Profile and Significant Pain Relief in an Open-Label Pilot Study of Patients with Osteoarthritis.Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial.Human blood-based anti-inflammatory solution inhibits osteoarthritis progression in a meniscal-tear rat study.Chondroprotective Effects of a Standardized Extract (KBH-JP-040) from Kalopanax pictus, Hericium erinaceus, and Astragalus membranaceus in Experimentally Induced In Vitro and In Vivo Osteoarthritis Models.Role of White Blood Cells in Blood- and Bone Marrow-Based Autologous Therapies
P2860
Q35608586-F2B51FCA-A8AE-4E2D-AFDE-F0AE14FC84DAQ36564183-9D32CDC3-73BE-48EF-B3A0-3A4421E1EA91Q37134474-631FBBA0-B8B0-4175-8A63-96C2A376FF3DQ38982848-E2CF76C6-F40C-4183-ADBB-528A84D1E539Q39351972-3191AD4E-022A-4604-A1FD-15996935FE15Q39621080-23C6BD9F-E2DF-464A-8FF2-4E61B72CFC8DQ45854928-8BD18EC0-C4B1-4D47-AF05-C1DE5AC2D9B3Q46865102-6801DF0B-3B73-43CC-9E51-5FB75737D291Q47137170-7AA40A70-BA96-4714-A064-A8048F189B40Q47672224-BB445615-870D-45E8-A0FB-ADC617BA2008Q51161025-9572F783-36A3-4B66-83C7-988338737630Q54982111-73D3570B-525D-4F71-A43F-A04F66C589BEQ57176528-57AECC72-09CC-4C59-AA5F-52D65413DA44
P2860
Autologous protein solution prepared from the blood of osteoarthritic patients contains an enhanced profile of anti-inflammatory cytokines and anabolic growth factors.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Autologous protein solution pr ...... s and anabolic growth factors.
@ast
Autologous protein solution pr ...... s and anabolic growth factors.
@en
Autologous protein solution pr ...... s and anabolic growth factors.
@nl
type
label
Autologous protein solution pr ...... s and anabolic growth factors.
@ast
Autologous protein solution pr ...... s and anabolic growth factors.
@en
Autologous protein solution pr ...... s and anabolic growth factors.
@nl
prefLabel
Autologous protein solution pr ...... s and anabolic growth factors.
@ast
Autologous protein solution pr ...... s and anabolic growth factors.
@en
Autologous protein solution pr ...... s and anabolic growth factors.
@nl
P2093
P2860
P356
P1476
Autologous protein solution pr ...... s and anabolic growth factors.
@en
P2093
Andrea Matuska
Christian Lattermann
Christopher Kaeding
Jacy Hoeppner
Jennifer Woodell-May
Krista O'Shaughnessey
Mark Klaassen
William King
P2860
P304
P356
10.1002/JOR.22671
P577
2014-07-01T00:00:00Z